IRIS
ORIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.004
EU - Europa 10.984
AS - Asia 3.537
SA - Sud America 237
Continente sconosciuto - Info sul continente non disponibili 62
OC - Oceania 21
AF - Africa 16
Totale 34.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.971
RU - Federazione Russa 3.439
UA - Ucraina 2.796
VN - Vietnam 1.476
GB - Regno Unito 1.161
SE - Svezia 1.106
DE - Germania 971
SG - Singapore 961
CN - Cina 873
FR - Francia 561
IT - Italia 413
FI - Finlandia 278
BR - Brasile 221
KR - Corea 127
PL - Polonia 109
EU - Europa 62
NL - Olanda 30
BE - Belgio 25
HK - Hong Kong 19
CA - Canada 18
AU - Australia 17
IE - Irlanda 16
AT - Austria 13
IN - India 13
DK - Danimarca 9
IQ - Iraq 9
MX - Messico 7
CZ - Repubblica Ceca 6
BD - Bangladesh 5
BG - Bulgaria 5
CO - Colombia 5
EG - Egitto 5
ES - Italia 5
HR - Croazia 5
JP - Giappone 5
PK - Pakistan 5
TR - Turchia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
HU - Ungheria 4
IL - Israele 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
AR - Argentina 3
BY - Bielorussia 3
LU - Lussemburgo 3
MM - Myanmar 3
NO - Norvegia 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
TW - Taiwan 3
BH - Bahrain 2
BN - Brunei Darussalam 2
CY - Cipro 2
EC - Ecuador 2
EE - Estonia 2
IM - Isola di Man 2
KE - Kenya 2
MA - Marocco 2
ME - Montenegro 2
SA - Arabia Saudita 2
VE - Venezuela 2
ZA - Sudafrica 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
GL - Groenlandia 1
GR - Grecia 1
ID - Indonesia 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
MC - Monaco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TC - Turks e Caicos 1
TH - Thailandia 1
Totale 34.861
Salva come PNG Salva come JPEG
Città #
Fairfield 2.739
Woodbridge 2.587
Houston 1.969
Dong Ket 1.474
Ann Arbor 1.448
Chandler 1.364
Ashburn 1.328
Wilmington 1.310
Seattle 1.081
Cambridge 933
Dearborn 890
Jacksonville 774
Southend 630
Nyköping 614
Boardman 472
Moscow 426
Singapore 384
Beijing 305
Lawrence 258
Princeton 258
Ogden 178
Düsseldorf 137
Shanghai 126
Des Moines 113
Kraków 108
Yubileyny 90
San Diego 88
Bremen 74
Grafing 66
Nanjing 62
The Dalles 61
Jinan 55
Los Angeles 55
London 49
Hefei 40
Dallas 36
Edinburgh 28
Norwalk 27
Shenyang 27
Brussels 25
New York 25
Helsinki 24
Kunming 24
San Mateo 24
Napoli 21
Nanchang 20
Rome 19
Auburn Hills 18
Guangzhou 18
São Paulo 18
Amsterdam 17
Hanover 17
Mirabella Eclano 16
Taiyuan 16
Zhengzhou 16
Hong Kong 15
Hangzhou 14
Kilburn 14
Hebei 13
Munich 12
Saint Petersburg 12
Dublin 11
Falls Church 11
Tianjin 11
Acton 10
Changsha 10
Fuzhou 10
Hounslow 10
Montemiletto 10
Naples 10
Copenhagen 9
Seongnam-si 9
Vienna 9
Chicago 8
Matawan 8
Ningbo 8
Seo-gu 8
Islington 7
Milan 7
Nürnberg 7
Wandsworth 7
Avellino 6
Dongjak-gu 6
Miami 6
Redwood City 6
Salerno 6
San Jose 6
Baghdad 5
Frankfurt am Main 5
Haikou 5
Lanzhou 5
Lauterbourg 5
New Bedfont 5
Ottawa 5
Phoenix 5
Sofia 5
Stockholm 5
Sydney 5
Taizhou 5
Xian 5
Totale 23.343
Salva come PNG Salva come JPEG
Nome #
Il microinfusore: quali indicazioni e quando iniziare 445
Sussidio didattico per gli studenti di igiene generale e applicata per il corso di laurea in scienze del servizio sociale 294
The good and bad effects of statins on insulin sensitivity and secretion 230
Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity 229
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. 221
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 217
Secrezioni ormonali ectopiche 213
Cardiopulmonary impairment in young women with polycystic ovary syndrome. 209
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 196
Effects of physical exercise on the female reproductive system. 195
Cardiological aspects of growth hormone and insulin-like growth factor-I. 193
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. 193
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. 189
Vitamin D and thyroid disease: to D or not to D? 187
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside. 187
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. 186
Endocrine secretions under abnormal light-dark cycles and in the blind. 182
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood and quality of life 181
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 181
Height, weight, height velocity of primary school population sample in Campania region. 180
THE IMPACT OF PROBAND GLUCOSE TOLERANCE STATUS ON BODY MASS INDEX (BMI) AND ADIPOSITY IN ADOLESCENT GIRLS AT HIGH RISK FOR POLYCYSTIC OVARY SYNDROME (PCOS) 179
Failure of long-term therapy with sodium valproate in Cushing's disease. 179
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 179
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. 178
The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome 177
Effects of neridronate treatment in elderly women with osteoporosis 176
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 176
Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome? 176
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women. 175
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept. 175
Ovulation induction in polycystic ovary syndrome 174
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance 173
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 173
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. 172
Effect of growth hormone on cardiac function. 171
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 171
The increase of leukocytes as a new putative marker of low- grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome 170
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. 170
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. 170
Lifestyle changes in the management of adulthood and childhood obesity. 170
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. 170
Adrenal mass: insight into pathogenesis and a common link with insulin resistance. 170
Auditory brainstem responses in thyroid diseases before and after therapy. 169
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005 169
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. 169
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review 169
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 169
Bisphenol A in Polycystic Ovary Syndrome and its Association with Liver-Spleen Axis. 168
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 168
Adiponectin levels in women with polycystic ovary syndrome 168
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. 167
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. 167
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 167
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women 165
Growth hormone status in morbidly obese subjects and correlation with body composition 165
GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. 165
Circulating ghrelin concentrations in the polycystic ovary syndrome 164
Current evidence on vitamin D deficiency and kidney transplant: What’s new? 164
Does raloxifene inhibit the growth of uterine fibroids? 163
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 163
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. 162
Terapia di associazione con insulina ed analoghi del GLP-1 162
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. 162
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 162
Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age 161
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine. 161
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 161
Antisperm antibodies in cryptorchidism before and after surgery. 160
Is the ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? 159
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors 159
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin 159
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 159
Prevalence of polycystic ovary morphology in a region of South Italy. 159
Cardiovascular risk of women with polycystic ovary syndrome 159
Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. 158
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 157
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis 157
Lymphocyte subset pattern in acromegaly. 157
Liver-spleen axis, Insulin-like Growth Factor-(IGF)-I axis and fat mass in overweight/obese females 157
Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study 157
Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response 157
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 156
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS 156
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome 156
Adrenocortical tumors and insulin resistance. What is the first step? 156
Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study 155
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS) 155
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women 155
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome 154
Anti-proliferative and pro-apoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women 154
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 154
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 154
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 151
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. 151
Thyroid function and morphology after a successful kidney transplantation 151
Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. 150
Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women 150
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome. 150
Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin. 150
Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. 150
Totale 17.384
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.967
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020608 0 0 0 0 0 0 0 0 0 136 424 48
2020/20214.882 395 96 438 184 618 96 525 37 124 440 129 1.800
2021/20222.163 139 314 34 771 76 45 253 199 141 116 69 6
2022/20234.290 523 136 215 458 498 796 115 566 571 120 223 69
2023/20241.231 134 71 77 54 54 34 25 316 268 56 12 130
2024/20255.429 86 505 15 133 86 499 1.693 2.000 322 90 0 0
Totale 35.289